Is HER2-Low a New Clinical Entity or Merely a Biomarker for an Antibody Drug Conjugate? - Heidi Ko; Rebecca A. Previs; Kyle C. Strickland; Jonathan Klein; Brian Caveney; Chiara Chiruzzi; Marcia Eisenberg; Eric A. Severson; Shakti Ramkissoon; Kamal S. Saini (Oncology and Therapy, 2023)